The "Organoids Are Us" symposium, held in the picturesque setting of Pattaya, Thailand, has successfully concluded, marking a significant milestone in the field of organoid research. The International Society of Organoid Research (ISoOR) was honored to be invited and to present at the conference.
International Society of Organoid Research (ISoOR) proudly announces the publication of Volume 2, Number 1 of its esteemed journal, Journal of Organoid & Bioscience.
From March 7 to 8, 2024, the International Society of Organoid Research (ISoOR) convened its 2024 annual meeting, after the successful conference in Singapore last year.
The International Society of Organoid Research (ISoOR) recently marked a significant advancement in the organoid field with the introduction of its new publication: Journal of Organoid & Bioscience (JOBs).
Novo Nordisk has paid $60 million to partner Valo Health on a project that will apply the US start-up's artificial intelligence-powered drug discovery engine to find new therapies for cardiometabolic diseases.
From August 7 to 8, 2023, the International Society of Organoid Research (ISoOR) held its inaugural annual meeting in Singapore. Hosted by ISoOR and co-organized by the Pharmacological Society (Singapore) and Scipolis, the conference was themed "Organoid: Accelerate Your Research."
The use of organoids in preclinical research has reached a tipping point, with U.S. FDA approval of the first drug to enter clinical trials on the basis of efficacy data derived only from these advanced cell models.